All News

Your daily dose of the clinical news you may have missed.

Measles cases are reported in 6 states, which is not a surprise to one pediatrician who points to the ongoing consequences of falling vaccination rates.

Low-dose calcium supplementation with 500 mg/day may be as protective against poor pregnancy outcomes as the WHO-recommended dose of 1500 mg/day.

New data suggest that dupilumab is safe for long-term use among patients with moderate-to-severe asthma or OCS-dependent severe asthma.

Your daily dose of the clinical news you may have missed.

The risk of asthma and poor outcomes was even greater among children with both conditions than among adults in this first study to compare the 2 populations.

The investigational combination opioid from Ensysce Biosciences is designed to deter abuse as well as prevent accidental or intentional overdose, the company said.

Heart disease has been the primary cause of death in the US for the last century, and yet 51% of adults do not recognize the fact.

Already high rates of readmission and mortality at 30 days rose significantly higher at 90 days, according to this National Readmissions Database review.

Unplanned emergency service and medication utilization make up the majority of costs of IBD care, reported researchers.

Dupilumab is the first agent approved to treat EoE in this vulnerable pediatric population.

Which medications are most effective for acute migraine management? A recent study assessed which ones appeared to work best based on reported patient experience.

Among more than 1.5 million persons hospitalized for COVID-19, a history of Crohn disease or ulcerative colitis significantly increased risk for poor outcomes.

Your daily dose of the clinical news you may have missed.

Survey findings presented at the Crohn’s & Colitis Congress suggest a need for education among some health care specialists about the clinical presentation of ulcerative colitis.

The effect of vagus nerve stimulation persons with narcolepsy revealed a specific, notable improvement in daytime sleepiness in a novel open-label study.

"A meaningful percentage" of individuals with Crohn disease are treated during maintenance with biologic doses ≥20%higher than recommended in FDA labeling.

Reports of migraine-related stigma were common in a recent population-based study, with nearly one-third reporting the experience often/very often.